Cargando…

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program

BACKGROUND: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colono...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikkelsen, Ellen M, Thomsen, Mette Kielsholm, Tybjerg, Julie, Friis-Hansen, Lennart, Andersen, Berit, Jørgensen, Jens Christian Riis, Baatrup, Gunnar, Njor, Sisse H, Mehnert, Frank, Rasmussen, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239110/
https://www.ncbi.nlm.nih.gov/pubmed/30519113
http://dx.doi.org/10.2147/CLEP.S181204
_version_ 1783371505159110656
author Mikkelsen, Ellen M
Thomsen, Mette Kielsholm
Tybjerg, Julie
Friis-Hansen, Lennart
Andersen, Berit
Jørgensen, Jens Christian Riis
Baatrup, Gunnar
Njor, Sisse H
Mehnert, Frank
Rasmussen, Morten
author_facet Mikkelsen, Ellen M
Thomsen, Mette Kielsholm
Tybjerg, Julie
Friis-Hansen, Lennart
Andersen, Berit
Jørgensen, Jens Christian Riis
Baatrup, Gunnar
Njor, Sisse H
Mehnert, Frank
Rasmussen, Morten
author_sort Mikkelsen, Ellen M
collection PubMed
description BACKGROUND: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colonoscopy. However, the validity of these data is unknown, and the incidence of complications is potentially underreported. OBJECTIVE: To evaluate the validity of the colonoscopy complications registered in the DCCSD by using medical records as the reference. Further, to evaluate the incidence of complications leading to hospital contact. METHODS: Among 14,671 individuals with a positive iFOBT result and a colonoscopy procedure performed from March 3, 2014 to December 31, 2014, we selected 295 individuals for medical record review. We calculated sensitivity as the proportion of true complications registered in the DCCSD out of all complications found in the medical records, and the positive predictive value (PPV) as the number of true complications in the DCCSD out of all DCCSD-registered complications. On the basis of the medical record data, we calculated the incidence proportion of hospital-registered complications overall and by subtype. RESULTS: In total, we reviewed 286 records and found 102 individuals with at least one complication. The sensitivity of the DCCSD for any complication was 29.4% (95% CI: 20.8–39.3) and the PPV was 88.2% (95% CI: 72.6–96.7). On the basis of the medical record data, the incidence proportion of any complication after colonoscopy was 0.70% (95% CI: 0.57–0.84) and that of perforation or lesion was 0.10% (95% CI: 0.06–0.17); bleeding, 0.41% (95% CI: 0.31–0.53); post-polypectomy syndrome, 0.16% (95% CI: 0.10–0.24); and other medical complications, 0.04 (95% CI: 0.02–0.09). CONCLUSION: The DCCSD has low sensitivity for complications, and improvements in data registration are warranted. The incidence proportion of any hospital-treated post-colonoscopy complication was 0.70% in 2014, which was the first year of the Danish national CRC screening program. This is within the range of complications reported by other studies.
format Online
Article
Text
id pubmed-6239110
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62391102018-12-05 Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program Mikkelsen, Ellen M Thomsen, Mette Kielsholm Tybjerg, Julie Friis-Hansen, Lennart Andersen, Berit Jørgensen, Jens Christian Riis Baatrup, Gunnar Njor, Sisse H Mehnert, Frank Rasmussen, Morten Clin Epidemiol Original Research BACKGROUND: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colonoscopy. However, the validity of these data is unknown, and the incidence of complications is potentially underreported. OBJECTIVE: To evaluate the validity of the colonoscopy complications registered in the DCCSD by using medical records as the reference. Further, to evaluate the incidence of complications leading to hospital contact. METHODS: Among 14,671 individuals with a positive iFOBT result and a colonoscopy procedure performed from March 3, 2014 to December 31, 2014, we selected 295 individuals for medical record review. We calculated sensitivity as the proportion of true complications registered in the DCCSD out of all complications found in the medical records, and the positive predictive value (PPV) as the number of true complications in the DCCSD out of all DCCSD-registered complications. On the basis of the medical record data, we calculated the incidence proportion of hospital-registered complications overall and by subtype. RESULTS: In total, we reviewed 286 records and found 102 individuals with at least one complication. The sensitivity of the DCCSD for any complication was 29.4% (95% CI: 20.8–39.3) and the PPV was 88.2% (95% CI: 72.6–96.7). On the basis of the medical record data, the incidence proportion of any complication after colonoscopy was 0.70% (95% CI: 0.57–0.84) and that of perforation or lesion was 0.10% (95% CI: 0.06–0.17); bleeding, 0.41% (95% CI: 0.31–0.53); post-polypectomy syndrome, 0.16% (95% CI: 0.10–0.24); and other medical complications, 0.04 (95% CI: 0.02–0.09). CONCLUSION: The DCCSD has low sensitivity for complications, and improvements in data registration are warranted. The incidence proportion of any hospital-treated post-colonoscopy complication was 0.70% in 2014, which was the first year of the Danish national CRC screening program. This is within the range of complications reported by other studies. Dove Medical Press 2018-11-13 /pmc/articles/PMC6239110/ /pubmed/30519113 http://dx.doi.org/10.2147/CLEP.S181204 Text en © 2018 Mikkelsen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mikkelsen, Ellen M
Thomsen, Mette Kielsholm
Tybjerg, Julie
Friis-Hansen, Lennart
Andersen, Berit
Jørgensen, Jens Christian Riis
Baatrup, Gunnar
Njor, Sisse H
Mehnert, Frank
Rasmussen, Morten
Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
title Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
title_full Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
title_fullStr Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
title_full_unstemmed Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
title_short Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
title_sort colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239110/
https://www.ncbi.nlm.nih.gov/pubmed/30519113
http://dx.doi.org/10.2147/CLEP.S181204
work_keys_str_mv AT mikkelsenellenm colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT thomsenmettekielsholm colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT tybjergjulie colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT friishansenlennart colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT andersenberit colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT jørgensenjenschristianriis colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT baatrupgunnar colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT njorsisseh colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT mehnertfrank colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram
AT rasmussenmorten colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram